Velev, M., Dalban, C., Chevreau, C., Gravis, G., Negrier, S., Laguerre, B., Gross-Goupil, M., Ladoire, S., Borchiellini, D., Geoffrois, L., Joly, F., Priou, F., Barthelemy, P., Laramas, M., Narciso, B., Thiery-Vuillemin, A., Berdah, J., Ferrari, V., Dominique Thomas, Q., Mione, C., Curcio, H., Oudard, S., Tantot, F., Escudier, B., Chabaud, S., Albiges, L., & Thibault, C. (2023). efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study. European journal of cancer, 182, 66–76. http://access.bl.uk/ark:/81055/vdc_100179405174.0x00002c